Stock GERN GERON CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Geron Corporation

Equities

GERN

US3741631036

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
3.79 USD +6.46% Intraday chart for Geron Corporation +2.71% +79.62%
Mar. 19 Geron Prices $150 Million Offering of Shares, Pre-Funded Warrants MT
Mar. 15 Sector Update: Health Care Stocks Ease Late Afternoon MT

Evolution of the average Target Price on Geron Corporation

Price target over the last 5 years

History of analyst recommendation changes

628.4gORG8Y9Gh5q3u02qYU7TVQtb5QgTOMQwga90U7cXQI.u2vWaOt8Yl0Zi7wF8cRLBRkeA8xnIpohr2TkhXqpBUmtRKd5ogRqVgKUjg~153c6164dff8d47a9bf2cd7e4661f932

Analyst Recommendations on Geron Corporation

Needham Adjusts Geron's Price Target to $5 From $4, Maintains Buy Rating MT
Goldman Sachs Adjusts Price Target on Geron to $5 From $4, Keeps Buy Rating MT
Goldman Sachs Upgrades Geron to Buy From Neutral, Price Target is $4 MT
Goldman Sachs Initiates Geron at Neutral With $3 Price Target MT
Needham Adjusts Price Target on Geron to $4 From $3, Maintains Buy Rating MT
B. Riley Lifts Geron's PT to $5 From $4, Keeps Buy Rating After Positive Topline Results From Phase III Trial of Imetelstat MT
Wedbush Lifts Geron's Price Target to $6 From $5, Keeps Outperform Rating MT
Wedbush Starts Geron at Outperform With $5 Price Target MT
Needham & Co Adjusts Geron Price Target to $3 From $2, Maintains Buy Rating MT
B. Riley Resumes Geron at Buy with $4 Price Target, Says Thesis Hinges on Potential Success of Imetelstat MT
Needham Trims Geron's Price Target to $2 From $3, Buy Rating Kept MT
Baird Starts Geron at Outperform With $4 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
3.79 USD
Average target price
5.083 USD
Spread / Average Target
+34.12%
High Price Target
6 USD
Spread / Highest target
+58.31%
Low Price Target
4.5 USD
Spread / Lowest Target
+18.73%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Geron Corporation

Needham & Co.
Goldman Sachs
B. Riley
Wedbush
Baird

Ratings for Geron Corporation

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GERN Stock
  4. Consensus Geron Corporation